Sherrie L. Aspinall

1.9k total citations
63 papers, 1.4k citations indexed

About

Sherrie L. Aspinall is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sherrie L. Aspinall has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Geriatrics and Gerontology, 15 papers in Economics and Econometrics and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sherrie L. Aspinall's work include Pharmaceutical Practices and Patient Outcomes (33 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Blood Pressure and Hypertension Studies (8 papers). Sherrie L. Aspinall is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (33 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Blood Pressure and Hypertension Studies (8 papers). Sherrie L. Aspinall collaborates with scholars based in United States, United Kingdom and Australia. Sherrie L. Aspinall's co-authors include Joseph T. Hanlon, Chester B. Good, Steven M. Handler, Mary Jo Pugh, Xinhua Zhao, Zachary A. Marcum, Francesca Cunningham, Carolyn T. Thorpe, Christine M. Ruby and Joshua D. Niznik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

Sherrie L. Aspinall

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherrie L. Aspinall United States	22	618	285	212	209	176	63	1.4k
Johanna Jyrkkä Finland	15	827 1.3×	477 1.7×	259 1.2×	157 0.8×	176 1.0×	36	1.5k
Mitja Kos Slovenia	20	474 0.8×	313 1.1×	138 0.7×	106 0.5×	151 0.9×	84	1.2k
Jean‐Baptiste Beuscart France	19	621 1.0×	337 1.2×	192 0.9×	128 0.6×	143 0.8×	98	1.3k
Douglas Steinke United Kingdom	27	404 0.7×	165 0.6×	95 0.4×	373 1.8×	245 1.4×	92	1.9k
Peter Loewen Canada	20	368 0.6×	174 0.6×	381 1.8×	240 1.1×	171 1.0×	86	1.5k
Virginia Hernandez Santiago United Kingdom	11	394 0.6×	217 0.8×	139 0.7×	160 0.8×	97 0.6×	24	876
Sven Schmiedl Germany	13	661 1.1×	298 1.0×	157 0.7×	97 0.5×	99 0.6×	51	1.2k
Ronald L. Castelino Australia	23	884 1.4×	444 1.6×	286 1.3×	139 0.7×	258 1.5×	103	1.7k
Jerry Avorn United States	15	302 0.5×	284 1.0×	251 1.2×	298 1.4×	184 1.0×	23	1.4k
Annemie Somers Belgium	19	1.0k 1.7×	468 1.6×	187 0.9×	71 0.3×	149 0.8×	57	1.4k

Countries citing papers authored by Sherrie L. Aspinall

Since Specialization

Citations

This map shows the geographic impact of Sherrie L. Aspinall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherrie L. Aspinall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherrie L. Aspinall more than expected).

Fields of papers citing papers by Sherrie L. Aspinall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherrie L. Aspinall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherrie L. Aspinall. The network helps show where Sherrie L. Aspinall may publish in the future.

Co-authorship network of co-authors of Sherrie L. Aspinall

This figure shows the co-authorship network connecting the top 25 collaborators of Sherrie L. Aspinall. A scholar is included among the top collaborators of Sherrie L. Aspinall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherrie L. Aspinall. Sherrie L. Aspinall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niznik, Joshua D., Xinhua Zhao, Maria K. Mor, et al.. (2022). Effect of Deintensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents. Diabetes Care. 45(7). 1558–1567. 14 indexed citations

Mor, Maria K., Florentina E. Sileanu, Xinhua Zhao, et al.. (2020). Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life. Journal of the American Geriatrics Society. 68(4). 725–735. 10 indexed citations

Niznik, Joshua D., Jacob N. Hunnicutt, Xinhua Zhao, et al.. (2020). Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes. Journal of the American Geriatrics Society. 68(4). 736–745. 29 indexed citations

Thorpe, Carolyn T., Florentina E. Sileanu, Maria K. Mor, et al.. (2020). Discontinuation of Statins in Veterans Admitted to Nursing Homes near the End of Life. Journal of the American Geriatrics Society. 68(11). 2609–2619. 23 indexed citations

Niznik, Joshua D., Xinhua Zhao, Meiqi He, et al.. (2019). Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia. Journal of the American Geriatrics Society. 68(4). 699–707. 21 indexed citations

Hanlon, Joseph T., Xinhua Zhao, Jennifer G. Naples, et al.. (2017). Central Nervous System Medication Burden and Serious Falls in Older Nursing Home Residents. Journal of the American Geriatrics Society. 65(6). 1183–1189. 44 indexed citations

Niznik, Joshua D., Xinhua Zhao, Tao Jiang, et al.. (2017). Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data. Drugs & Aging. 34(12). 925–939. 18 indexed citations

Aspinall, Sherrie L., Xinhua Zhao, Todd P. Semla, et al.. (2014). Epidemiology of Drug–Disease Interactions in Older Veteran Nursing Home Residents. Journal of the American Geriatrics Society. 63(1). 77–84. 11 indexed citations

Aspinall, Sherrie L., Kenneth J. Smith, Chester B. Good, et al.. (2013). Incremental Cost Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agent Clinics for Non-Dialysis-Dependent Chronic Kidney Disease Patients. Applied Health Economics and Health Policy. 11(6). 653–660. 6 indexed citations

10.

Gellad, Walid F., Sherrie L. Aspinall, Steven M. Handler, et al.. (2012). Use of Antipsychotics Among Older Residents in VA Nursing Homes. Medical Care. 50(11). 954–960. 39 indexed citations

11.

Aspinall, Sherrie L., Francesca Cunningham, Xinhua Zhao, et al.. (2012). Impact of Pharmacist-Managed Erythropoiesis-Stimulating Agents Clinics for Patients With Non–Dialysis-Dependent CKD. American Journal of Kidney Diseases. 60(3). 371–379. 20 indexed citations

12.

Aspinall, Sherrie L., Kenneth J. Smith, Francesca Cunningham, & Chester B. Good. (2011). Incremental cost-effectiveness of various monthly doses of vardenafil. Value in Health. 14(1). 97–101. 2 indexed citations

13.

Aspinall, Sherrie L., Xinhua Zhao, Steven M. Handler, et al.. (2010). The Quality of Warfarin Prescribing and Monitoring in Veterans Affairs Nursing Homes. Journal of the American Geriatrics Society. 58(8). 1475–1480. 13 indexed citations

14.

Hanlon, Joseph T., et al.. (2009). Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. The American journal of geriatric pharmacotherapy. 7(1). 20–25. 40 indexed citations

15.

Aspinall, Sherrie L., Jessica S. Banthin, Chester B. Good, G. Edward Miller, & Francesca Cunningham. (2009). VA pharmacy users: how they differ from other veterans.. PubMed. 15(10). 701–8. 4 indexed citations

16.

Rodriguez, Keri L., Kelly H. Burkitt, Mary Ann Sevick, et al.. (2009). Assessing Processes of Care to Promote Timely Initiation of Antibiotic Therapy for Emergency Department Patients Hospitalized for Pneumonia. The Joint Commission Journal on Quality and Patient Safety. 35(10). 509–518. 4 indexed citations

17.

Hanlon, Joseph T., Sherrie L. Aspinall, Todd P. Semla, et al.. (2008). Consensus Guidelines for Oral Dosing of Primarily Renally Cleared Medications in Older Adults. Journal of the American Geriatrics Society. 57(2). 335–340. 63 indexed citations

18.

Aspinall, Sherrie L., et al.. (2008). Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones. Journal of Managed Care Pharmacy. 14(1). 34–40. 17 indexed citations

19.

Aspinall, Sherrie L., Joshua P. Metlay, Judith H. Maselli, & Ralph Gonzales. (2007). Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.. PubMed. 13(5). 241–8. 6 indexed citations

20.

Aspinall, Sherrie L., Chester B. Good, Peter Glassman, & Michael Valentino. (2005). The Evolving Use of Cost-Effectiveness Analysis in Formulary Management Within the Department of Veterans Affairs. Medical Care. 43(7). II–20. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact